Specifically, we have identified an expansion of CD16+ T cells in PCP, as well as an increase in CD57+ CD8+ T cells expressing immune checkpoints, FCRL5+ B cells, and CCR2+ CCR5+ monocytes in ICI-ILD, which may play a pathogenic role. Here, FCRL5 is linked to interstitial lung disease.